Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:carboplatin (1:1 mol/mol) |
PharmacoGx | BRD-A02303741:carboplatin (1:1 mol/mol) |
A549 | lung | CTRPv2 | 3 |
DU-145 | prostate | CTRPv2 | 2 |
AsPC-1 | pancreas | CTRPv2 | 2 |
NCI-H1869 | lung | CTRPv2 | 2 |
CCF-STTG1 | central nervous system | CTRPv2 | 2 |
OAW-28 | ovary | CTRPv2 | 2 |
HeLa | cervix | CTRPv2 | 2 |
LOXIMVI | haematopoietic and lymphoid tissue | CTRPv2 | 2 |
NCI-H520 | lung | CTRPv2 | 2 |
MKN74 | stomach | CTRPv2 | 2 |
Feature Type | Standardized | Nominal ANOVA | |||
---|---|---|---|---|---|
mRNA | LDLRAD1 | CTRPv2 | AAC | 0.24 | 7e-11 |
mRNA | CCDC153 | CTRPv2 | AAC | 0.21 | 3e-08 |
mRNA | IFT140 | CTRPv2 | AAC | 0.2 | 6e-08 |
mRNA | PRR26 | CTRPv2 | AAC | 0.18 | 1e-06 |
mRNA | DNAJB13 | CTRPv2 | AAC | 0.18 | 2e-06 |
mRNA | ADI1 | CTRPv2 | AAC | 0.17 | 2e-06 |
mRNA | GPR142 | CTRPv2 | AAC | 0.17 | 3e-06 |
mRNA | CEACAM16 | CTRPv2 | AAC | 0.17 | 3e-06 |
mRNA | NCBP2L | CTRPv2 | AAC | 0.17 | 4e-06 |
mRNA | OR52I2 | CTRPv2 | AAC | 0.16 | 7e-06 |